Evidence map›Paper›PMID 34288008›Full record

ArticleAmerican journal of industrial medicine2021

Serum Th-2 cytokines and FEV

Michael D Weiden, Ankura Singh, David G Goldfarb, Barbara Putman, Rachel Zeig-Owens, Theresa Schwartz, Hillel W Cohen, David J Prezant

Open access · hybridAbstract read
In one paragraph

Article in American journal of industrial medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Serum Th-2 cytokines and FEVAmerican journal of industrial medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Michael D WeidenThe Bureau of Health Services and the FDNY World Trade Center Health Program, Brooklyn, New York, USA.
Ankura SinghThe Bureau of Health Services and the FDNY World Trade Center Health Program, Brooklyn, New York, USA.
David G GoldfarbThe Bureau of Health Services and the FDNY World Trade Center Health Program, Brooklyn, New York, USA.
Barbara PutmanDepartment of Medicine, New York University School of Medicine, New York, New York, USA.
Rachel Zeig-OwensThe Bureau of Health Services and the FDNY World Trade Center Health Program, Brooklyn, New York, USA.ORCID 0000-0002-8679-2306
Theresa SchwartzThe Bureau of Health Services and the FDNY World Trade Center Health Program, Brooklyn, New York, USA.
Hillel W CohenDepartment of Epidemiology and Population Health, Division of Epidemiology, Albert Einstein College of Medicine, Bronx, New York, USA.
David J PrezantThe Bureau of Health Services and the FDNY World Trade Center Health Program, Brooklyn, New York, USA.
Albert Einstein College of Medicine · USGhent University · BENew York City Fire Department · US

Funding

Treatment response of WTC related airway injuryU01OH011682 · OH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WEIDEN, MICHAEL D. · 2019 to 2020
$1.6M
NIOSH CDC HHS U01 OH011682
6 · The paper itself

Abstract

backgroundAccelerated-FEV

methodsSerum was drawn from Fire Department of the City of New York (FDNY) firefighters 1-6 months (early) (N = 816) and 12-13 years (late) (N = 983) after 9/11/2001. Th-2 biomarkers IL-4, IL-13, and IL-5 were assayed by multiplex Luminex. Individual FEV

resultsIn WTC-exposed firefighters with accelerated-FEV

conclusionsIn WTC-exposed firefighters with accelerated-FEV

Indexed as

FirefightersOccupational ExposureSeptember 11 Terrorist AttacksCytokinesHumansLongitudinal StudiesCytokinescohort studiesFEV1 slopefirefightingTh-2 biomarkersWorld Trade Center

Identifiers

PMID34288008
PMCPMC9290799
OpenAlexW3186471463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.